Search

HAPLO-iPS • COST ACTION CA21151

WG1 • Sample selection

Source material screening, selection, collection and tracing

Working Group 1 is responsible for source material screening, selection, collection, and tracing. Together with immunology and cord blood bank experts from a number of countries, the team shall establish minimum criteria for sample quality, data and traceability in order to develop a common understanding of the (HLA) cord blood sample selection procedure.

Objectives

WG1 Leaders

CG-_0000_Sergio Querol
Sergio Querol
WG1 Leader
Banc de Sang i Teixits
squerol@bst.cat
Spain
Spain
CG-_0003_Meral Beksac
Meral Beksac
WG1 Co-leader
Ankara University
beksac@medicine.ankara.edu.tr
Turkey
Turkey

Description of Work

T1.1

Review of initiatives and literature on generation on hiPSC generation from haplo-selected CB samples (coordination and communication opportunities to understand the diversity and commonalities of approaches in different centres/countries) and organize an immunology expert meeting for CB sample selection (involving experts in HLA and non-HLA rejection and tolerance mechanisms).

T1.2

Contact (email, online conferences) CB EU banks for sample availability.

T1.3

CB bank expert meeting to establish minimal HAPLO-iPS criteria for sample quality (identifying appropriate standards for starting materials), data and traceability.

Deliverables and milestones

D1.1

Report on the common understanding of the haplo-selected CB samples selection procedure (M6).

D1.2

Report on the coordination of information seeking tracing, collection and data curation of the selected samples. (M15) M1.1: Decision on which CB samples need to be used for hiPSC generation and assess their availability.

WG1 Participants

Belen Alvarez-Palomo
Working Group: WG1, WG7
Banc de Sang i Teixits
Spain
Spain
Aleksandar Petlichkovski
Working Group: WG1, WG3, WG6
Faculty of Medicine
North Macedonia
North Macedonia
Alice Hägg
Working Group: WG1, WG2
Lund University
Sweden
Sweden
Annelise Bennaceur Griscelli
Working Group: WG1, WG2, WG3, WG7
University Paris Saclay
France
France
Mariastefania Antica
Working Group: WG1, WG6
Rudjer Boskovic Institute
Croatia
Croatia
Meral Beksac
Working Group: WG1, WG7
Ankara University
Turkey
Turkey
Carlota Alvarez Lucena
Working Group: WG1, WG2
Instituto de Investigaciones Biomédicas "Alberto Sols"
Spain
Spain
Dejan Dobrijevic
Working Group: WG1, WG2, WG7
University of Novi Sad
Serbia
Serbia
Göksun Demirel
Working Group: WG1, WG2, WG3, WG4
Cukurova Universitesi
Turkey
Turkey
Diana Chaker
Working Group: WG1, WG2, WG3, WG4, WG5, WG6, WG7
CITHERA
France
France
Dinko Mitrecic
Working Group: WG1, WG2, WG5, WG6
University of Zagreb
Croatia
Croatia
Domenico Vittorio Delfino
Working Group: WG1, WG6
University of Perugia
Italy
Italy
Loading more